JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ALEXANDER, W. F.
Right arrow Articles by KOTKIS, A. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ALEXANDER, W. F.
Right arrow Articles by KOTKIS, A. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 58, Issue 4, 439-453, 1936
Copyright © 1936 by American Society for Pharmacology and Experimental Therapeutics


THE PROPERTIES OF THE PHYSIOLOGICALLY ACTIVE SUBSTANCE IN THE BODY RESULTING FROM THE ADMINISTRATION OF ACETYL-BETA-METHYLCHOLINE CHLORIDE BY IONTOPHORESIS

W. F. ALEXANDER 1 and A. J. KOTKIS 1

1 From the Departments of Micro-anatomy and Internal Medicine, St. Louis University School of Medicine

1. A substance is present in the perfusate from the limb of the experimental animal after the iontophoresis of acetyl-beta-methylcholine chloride which in its physiological action is identical with that of the uniontophorized compound.

2. This substance is present in the perfusate in the concentration of the order of one part in 1 x 106 as is shown by the tests on the cat.

3. Iontophoresis with normal saline solution produces only negative results.

4. The substance present in the perfusate can be recovered and concentrated, so that it will produce physiological actions identical with those of a known concentration of acetyl-beta-methylcholine chloride, namely, drop in blood pressure, positive inotropic and negative chronotropic effects on the heart, salivation, in some instances urination and in other instances increased bronchial secretion.

5. The effect of the active substance present in the perfusate is abolished by atropine sulphate.

6. The cation of ABMCC is stable and the substance present in the perfusate is similar to acetyl-beta-methylcholine chloride.

Submitted on August 6, 1936







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1936 by the American Society for Pharmacology and Experimental Therapeutics.